Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates - PubMed (original) (raw)
Antibiotic susceptibilities and therapeutic options for Ureaplasma urealyticum infections in neonates
K B Waites et al. Pediatr Infect Dis J. 1992 Jan.
Abstract
The appreciation of Ureaplasma urealyticum as a human pathogen and documentation of antibiotic resistance have heightened interest in drug susceptibilities and treatment alternatives for patients infected with this organism. Neonates pose special problems when therapy must be considered because of potential toxicities, clinical unfamiliarity or lack of experience. Forty-three isolates of U. urealyticum obtained from the lower respiratory tracts of neonates were tested against chloramphenicol, ciprofloxacin, clindamycin, erythromycin, doxycycline, and gentamicin by a microbroth dilution technique in 10B broth. In vitro resistance was observed in 1 or more strains for each of the drugs tested, except for erythromycin (minimal inhibitory concentration (MIC) range, 0.125 to 4 micrograms/ml, MIC90 = 2 micrograms/ml). MIC90 values for the remaining five antibiotics were: doxycycline, 2 micrograms/ml; chloramphenicol, 8 micrograms/ml; ciprofloxacin, 8 micrograms/ml; clindamycin, 16 micrograms/ml; and gentamicin, 32 micrograms/ml. The effect of pH and/or media components on MICs was evaluated by comparing MICs of American Type Culture Collection reference strain Staphylococcus aureus 29213 obtained in Mueller-Hinton broth (pH 7.2 to 7.4) and 10B broth (pH 6.0). No appreciable effect was detected for ciprofloxacin, chloramphenicol or doxycycline, whereas gentamicin, erythromycin and clindamycin all had MICs elevated by one to several dilutions when tested in 10B broth. In some instances the difference was sufficient to alter the interpretation of the MIC. Clinical experience in treating neonatal ureaplasmal infections is reviewed along with recommendations for obtaining cultures, initiating and monitoring efficacy of therapy.
Similar articles
- Susceptibilities of neonatal respiratory isolates of Ureaplasma urealyticum to antimicrobial agents.
Matlow A, Th'ng C, Kovach D, Quinn P, Dunn M, Wang E. Matlow A, et al. Antimicrob Agents Chemother. 1998 May;42(5):1290-2. doi: 10.1128/AAC.42.5.1290. Antimicrob Agents Chemother. 1998. PMID: 9593171 Free PMC article. - Therapeutic considerations for Ureaplasma urealyticum infections in neonates.
Waites KB, Crouse DT, Cassell GH. Waites KB, et al. Clin Infect Dis. 1993 Aug;17 Suppl 1:S208-14. doi: 10.1093/clinids/17.supplement_1.s208. Clin Infect Dis. 1993. PMID: 8399918 Review. - Evaluation of the Etest for susceptibility testing of Mycoplasma hominis and Ureaplasma urealyticum.
Dósa E, Nagy E, Falk W, Szöke I, Ballies U. Dósa E, et al. J Antimicrob Chemother. 1999 Apr;43(4):575-8. doi: 10.1093/jac/43.4.575. J Antimicrob Chemother. 1999. PMID: 10350390 - In vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis, and Ureaplasma urealyticum to sparfloxacin and PD 127391.
Waites KB, Duffy LB, Schmid T, Crabb D, Pate MS, Cassell GH. Waites KB, et al. Antimicrob Agents Chemother. 1991 Jun;35(6):1181-5. doi: 10.1128/AAC.35.6.1181. Antimicrob Agents Chemother. 1991. PMID: 1929260 Free PMC article. - Role of erythromycin for treatment of incipient chronic lung disease in preterm infants colonised with Ureaplasma urealyticum.
Bührer C, Hoehn T, Hentschel J. Bührer C, et al. Drugs. 2001;61(13):1893-9. doi: 10.2165/00003495-200161130-00002. Drugs. 2001. PMID: 11708762 Review.
Cited by
- Antibiotics in neonatal infections: a review.
Fanos V, Dall'Agnola A. Fanos V, et al. Drugs. 1999 Sep;58(3):405-27. doi: 10.2165/00003495-199958030-00003. Drugs. 1999. PMID: 10493270 Review. - Failure of erythromycin to eliminate airway colonization with ureaplasma urealyticum in very low birth weight infants.
Baier RJ, Loggins J, Kruger TE. Baier RJ, et al. BMC Pediatr. 2003 Sep 4;3:10. doi: 10.1186/1471-2431-3-10. Epub 2003 Sep 4. BMC Pediatr. 2003. PMID: 12956892 Free PMC article. Clinical Trial. - Ureaplasma urealyticum intrauterine infection: role in prematurity and disease in newborns.
Cassell GH, Waites KB, Watson HL, Crouse DT, Harasawa R. Cassell GH, et al. Clin Microbiol Rev. 1993 Jan;6(1):69-87. doi: 10.1128/CMR.6.1.69. Clin Microbiol Rev. 1993. PMID: 8457981 Free PMC article. Review. - Transplacental transfer of Azithromycin and its use for eradicating intra-amniotic ureaplasma infection in a primate model.
Acosta EP, Grigsby PL, Larson KB, James AM, Long MC, Duffy LB, Waites KB, Novy MJ. Acosta EP, et al. J Infect Dis. 2014 Mar;209(6):898-904. doi: 10.1093/infdis/jit578. Epub 2013 Oct 31. J Infect Dis. 2014. PMID: 24179112 Free PMC article. - Spontaneously resolving Ureaplasma urealyticum meningitis.
Neal TJ, Roe MF, Shaw NJ. Neal TJ, et al. Eur J Pediatr. 1994 May;153(5):342-3. doi: 10.1007/BF01956415. Eur J Pediatr. 1994. PMID: 8033923
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical